• Dr. Reddy’s reported 4.2% quarter-on-quarter (QoQ) growth in its consolidated revenues for the quarter ended June (Q1FY22). On a year-on-year (YoY) basis, it increased by 12%.
  • Its expenses for the quarter were up by 11.4% QoQ and up by 24.7% YoY.
  • The pharma company’sconsolidated profit before tax fell 31.8% QoQ and 38.3% YoY..
  • The net profit of the company decreased by 31.7% QoQ and 36% on a YoY basis during the June 2021 quarter.
  • The earnings per share (EPS) of Dr. Reddy’sstood at 23 during Q1FY22.

Dr. Reddy’s Financial Statements for Q1FY22:

(Rs, crores) Q1FY21 Q4FY21 Q1FY22 QoQ (%) YoY (%)
Total Income 4,514 4,851 5,053 4.2% 12.0%
Total Expenses 3,621 4,054 4,514 11.4% 24.7%
Profit before tax 901 815 556 -31.8% -38.3%
Tax 306 258 175 -32.0% -42.7%
Profit after tax 595 557 380 -31.7% -36.0%
Earnings per share 35.9 33.6 23.0    

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results